MDXG sentiment intelligence

Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks

Tone

Neutral 50/100

Event

Earnings

Published

13 Jul 2026 12:30

Source

Market source

Form 4 MiMedx Group Inc For: 7 July By Investing.com

This article from Investing.com announces the filing of a Form 4 for MiMedx Group Inc. on July 7th. It indicates that the company's stock symbol is MDXG, which experienced a 1.67% increase. The content provided is primarily a placeholder for the actual Form 4 details, surrounded

Tone

Neutral 50/100

Event

Market update

Published

07 Jul 2026 18:10

Source

Investing.com Nigeria

MIMEDX (MDXG) CFO has shares withheld to cover RSU tax liability

MIMEDX Group, Inc.'s CFO, Doug Rice, reported a routine share disposition where 12,749 shares of common stock were withheld at $3.95 per share to cover tax liabilities upon the vesting of restricted stock units. This transaction is considered an automatic share disposition for ta

Tone

Neutral 50/100

Event

Market update

Published

07 Jul 2026 12:41

Source

Stock Titan

MDXG - Mimedx Group Inc Latest SEC Filings

This article provides a detailed financial overview of Mimedx Group Inc (MDXG), including its latest stock performance, key financial metrics, market capitalization, and various valuation ratios. It also lists insider and institutional ownership, profitability, and sales growth f

Tone

Neutral 50/100

Event

Market update

Published

29 Jun 2026 02:40

Source

Finviz

Enterprise value to EBIT forward of MiMedx Group, Inc – NASDAQ:MDXG

This article provides financial information for MiMedx Group, Inc (NASDAQ: MDXG), specifically focusing on its Enterprise Value to EBIT (Earnings Before Interest and Taxes) forward metric. It details where to find this data within the TradingView platform's market information for

Tone

Neutral 50/100

Event

Earnings

Published

28 Jun 2026 02:40

Source

TradingView

Enterprise value to EBIT forward of MiMedx Group, Inc – BOATS:MDXG

The article focuses on the enterprise value to EBIT forward metric for MiMedx Group, Inc (MDXG) within the Blue Ocean Alternative Trade System (BOATS). It appears to be a financial data page from TradingView, displaying the metric's value, change, and percentage change. The conte

Tone

Neutral 50/100

Event

Market update

Published

27 Jun 2026 16:39

Source

TradingView

Price to earnings forward of MiMedx Group, Inc – NASDAQ:MDXG

This article provides the "Price to earnings forward" metric for MiMedx Group, Inc (NASDAQ: MDXG) on TradingView. It indicates that the market was closed at the time of viewing, with no trades having occurred. The content mainly consists of navigation links and footers typical of

Tone

Neutral 50/100

Event

Earnings

Published

27 Jun 2026 07:09

Source

TradingView

MiMedx Group, Inc. Actuals & Estimates (BOATS:MDXG)

This article provides an overview of MiMedx Group, Inc. (MDXG) financials and analyst estimates. It covers historical financial data, future price forecasts from analysts, key dates like the next earnings report, and detailed financial figures including recent earnings, revenue,

Tone

Neutral 50/100

Event

Earnings

Published

27 Jun 2026 01:39

Source

TradingView

Price to book forward of MiMedx Group, Inc – BOATS:MDXG

This article provides the "Price to book forward" financial metric for MiMedx Group, Inc (MDXG). It is presented as part of TradingView's financial data for the company. The page indicates that no trades were made when the market was closed.

Tone

Neutral 50/100

Event

Market update

Published

26 Jun 2026 23:40

Source

TradingView

Price to sales forward of MiMedx Group, Inc – NASDAQ:MDXG

This article provides financial data, specifically the "Price to sales forward" for MiMedx Group, Inc (NASDAQ: MDXG). The content appears to be a truncated financial data display page from TradingView, offering an overview, financials, news, and other market-related information f

Tone

Neutral 50/100

Event

Market update

Published

26 Jun 2026 21:40

Source

TradingView

MiMedx Group, Inc. Actuals & Estimates (NASDAQ:MDXG)

This article provides an overview of MiMedx Group, Inc. (NASDAQ: MDXG) financials, stock performance, and analyst estimates. It includes current stock price, historical highs and lows, market capitalization, volatility, earnings reports, revenue, net income, and future forecasts,

Tone

Neutral 50/100

Event

Earnings

Published

26 Jun 2026 08:40

Source

TradingView

MIMEDX (MDXG) CCO sees 19,820 shares withheld to cover tax on RSU vesting

MIMEDX GROUP, INC.'s Chief Commercial Officer, Kimberly Maersk-Moller, had 19,820 shares withheld by the company at $3.83 per share to cover tax obligations upon the vesting of restricted stock. This was a tax-withholding disposition, not an open-market sale, and she retains a su

Tone

Neutral 50/100

Event

Market update

Published

25 Jun 2026 20:12

Source

Stock Titan

MDXG Forecast — Price Target — Prediction for 2027

This article provides a forecast for MiMedx Group, Inc (MDXG) stock, including analyst price targets, past performance, and financial data. Five analysts predict a max estimate of $8.00 and a min estimate of $5.00, while the stock currently trades at $3.81. Key financial metrics,

Tone

Neutral 50/100

Event

Analyst action

Published

25 Jun 2026 17:39

Source

TradingView

MiMedx Group (MDXG) Stock Faces Mixed Analyst Target Changes After Guidance Cut

Analysts have issued mixed reactions to MiMedx Group's recent guidance cut, with some trimming price targets by US$1 to US$5, while the modeled fair value remains at US$6.50. This reflects a balance between optimism for the business and concerns over execution and current stock v

Tone

Neutral 50/100

Event

Analyst action

Published

20 Jun 2026 22:39

Source

Market source

MiMedx Group Inc (MDXG) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of MiMedx Group Inc (MDXG), noting its current price momentum score of 6.60 and its ranking in the Biotechnology & Medical Research industry. It details the stock's support and resistance levels, and analyzes various technical indicators

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 21:41

Source

TradingKey

MiMedx Group Inc (MDXG) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of MiMedx Group Inc (MDXG), noting its current valuation score of 6.65, which ranks 314 out of 388 in the Biotechnology & Medical Research industry. The company's P/E ratio is 17.37, significantly below its recent high but substantially

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 09:39

Source

TradingKey

MiMedx Group Inc (MDXG) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of MiMedx Group Inc (MDXG), listing its major shareholders and institutional holdings as of recent reporting periods. It identifies top individual shareholders like EW Healthcare Partners and BlackRock, categorizes shareholders by ty

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 00:10

Source

TradingKey

MiMedx Shareholders Back Board, Pay and Bylaw Changes

MiMedx Group shareholders have approved amendments to the company's bylaws, including raising the cap on public-company boards its CEO can serve on to three. Additionally, investors re-elected seven directors, endorsed executive compensation, and ratified Deloitte & Touche LLP as

Tone

Neutral 50/100

Event

Market update

Published

17 Jun 2026 22:10

Source

The Globe and Mail

MiMedx (NASDAQ: MDXG) director Tiffany Olson receives 50,913-share stock grant

MiMedx director Tiffany Olson was granted 50,913 shares of common stock at $3.64 per share as a restricted stock grant for non-employee directors. This equity award vests upon the earlier of 12 months or the next meeting of shareholders and is exempt under Rule 16b-3. Following t

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 19:10

Source

Stock Titan

MIMEDX (NASDAQ: MDXG) awards 50,913 restricted shares to director Todd Newton

MIMEDX (NASDAQ: MDXG) director Todd Newton was awarded 50,913 restricted shares of common stock as part of his annual compensation. The shares were granted at a reference price of $3.64 each and are exempt under Rule 16b-3. The award will vest after 12 months or at the next share

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 15:08

Source

Stock Titan

MIMEDX (MDXG) director William Hawkins receives 50,913-share restricted stock grant

MIMEDX Group, Inc. director William A. Hawkins was granted 50,913 shares of restricted common stock at $3.64 per share as compensation for his non-employee director service. This grant is exempt under Rule 16b-3 and vests upon the earlier of 12 months or the next shareholders' me

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 15:08

Source

Stock Titan

Director Dorothy Puhy granted 50,913 MDXG shares in annual stock award

MiMedx Group director Dorothy E. Puhy received an annual restricted stock award of 50,913 shares of common stock, valued at $3.64 per share. This transaction, exempt under Rule 16b-3, increases her direct holdings to 108,510 shares. The award is part of her compensation as a non-

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 15:08

Source

Stock Titan

MiMedx (NASDAQ: MDXG) awards 50,913 restricted shares to director

Tone

Neutral 50/100

Event

Market update

Published

12 Jun 2026 07:00

Source

Stock Titan